LOX-1, oxidative stress and inflammation: A novel mechanism for diabetic cardiovascular complications

Cardiovascular Drugs and Therapy

Volumn 25, Issue 5, 2011, Pages 451-459

  Yan, Meiling ^a   Mehta, Jawahar L ^b   Zhang, Weifang ^a   Hu, Changping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Cardiovascular complications; Diabetes; LOX 1; Nephropathy

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WOUND HEALING IMPAIRMENT;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; HUMANS; INFLAMMATION; OXIDATIVE STRESS; SCAVENGER RECEPTORS, CLASS E;

EID: 83055187956     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-011-6342-4     Document Type: Article

References (94)

1. S Wild G Roglic A Green R Sicree H King 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047 53 15111519 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
2. B Kahn J Flier 2000 Obesity and insulin resistance J Clin Invest 106 473 81 10953022 10.1172/JCI10842 1:CAS:528:DC%2BD3cXlvFCltbw%3D (Pubitemid 30666380)
3. DT Graves RA Kayal 2008 Diabetic complications and dysregulated innate immunity Front Biosci 13 1227 39 17981625 10.2741/2757 1:CAS:528: DC%2BD1cXhs1Cgsr4%3D (Pubitemid 351594707)
4. T Mazzone A Chait J Plutzky 2008 Addressing cardiovascular disease risk in diabetes: insights from mechanistic studies Lancet 371 1800 9 18502305 10.1016/S0140-6736(08)60768-0 1:CAS:528:DC%2BD1cXmt1Ontro%3D (Pubitemid 351697956)
5. J Karalliedde L Gnudi 2008 Future strategies to prevent renal microvascular disease complications in diabetes Future Cardiol. 4 77 83 19804273 10.2217/14796678.4.1.77
6. T Sawamura N Kume T Aoyama H Moriwaki H Hoshikawa Y Aiba, et al. 1997 An endothelial receptor for oxidized low-density lipoprotein Nature 386 73 7 9052782 10.1038/386073a0 1:CAS:528:DyaK2sXhslCnsLg%3D (Pubitemid 27130922)
7. H Yoshida N Kondratenko S Green D Steinberg O Quehenberger 1998 Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor Biochem J 334 9 13 9693095 1:CAS:528:DyaK1cXls1Sls70%3D (Pubitemid 28420964)
8. H Kataoka N Kume S Miyamoto M Minami M Morimoto K Hayashida, et al. 2001 Oxidized LDL modulates Bax/Bcl-2 through the lectin-like ox-LDL receptor-1 in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 21 955 60 11397703 10.1161/01.ATV.21.6.955 1:CAS:528:DC%2BD3MXksVartrY%3D (Pubitemid 34168652)
9. P Martín-Fuentes F Civeira D Recalde AL García-Otín E Jarauta I Marzo, et al. 2007 Individual variation of scavenger receptor expression in human macrophages with oxidized low-density lipoprotein is associated with a differential inflammatory response J Immunol 179 3242 8 17709540
10. VV Kunjathoor M Febbraio EA Podrez KJ Moore L Andersson S Koehn, et al. 2002 Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages J Biol Chem 277 49982 8 12376530 10.1074/jbc.M209649200 1:CAS:528:DC%2BD38XpsFakurs%3D (Pubitemid 36014449)
11. CP Hu JL Mehta 2008 Biology of LOX-1 in relation to atherogenesis Future lipidol. 3 689 96 10.2217/17460875.3.6.689 1:CAS:528:DC%2BD1cXhsVKgs7jF
12. S Ogura A Kakino Y Sato Y Fujita S Iwamoto K Otsui, et al. 2009 LOX-1: The multifunctional receptor underlying cardiovascular dysfunction Circ J 73 1993 9 19801851 10.1253/circj.CJ-09-0587 1:CAS:528:DC%2BD1MXhsVKgsb%2FJ
13. M Nagase S Hirose T Sawamura T Masaki T Fujita 1997 Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats Biochem Biophys Res Commun 237 496 8 9299391 10.1006/bbrc.1997.7176 1:CAS:528:DyaK2sXmtV2gsrk%3D (Pubitemid 27434712)
14. M Chen M Nagase T Fujita S Narumiya T Masaki T Sawamura 2001 Diabetes Enhances Lectin-like Oxidized LDL Receptor-1 (LOX-1) Expression in the Vascular Endothelium: Possible Role of LOX-1 Ligand and AGE Biochem Biophys Res Commun 287 962 8 11573959 10.1006/bbrc.2001.5674 1:CAS:528:DC%2BD3MXntV2ns74%3D (Pubitemid 32953570)
15. H Chen D Li T Sawamura K Inoue J Mehta 2000 Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: Modulation by losartan Biochem Biophys Res Commun 276 1100 4 11027596 10.1006/bbrc.2000.3532 1:CAS:528:DC%2BD3cXntFOrurg%3D
16. T Ueno S Kaname K Takaichi M Nagase A Tojo ML Onozato, et al. 2003 LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidneys of chronic renal failure rats Hypertens Res 26 117 22 12661921 10.1291/hypres.26.117 1:CAS:528:DC%2BD3sXjtVelsrg%3D (Pubitemid 36193107)
17. JA Beckman MA Creager P Libby 2002 Diabetes and atherosclerosis: epidemiology, pathophysiology, and management JAMA. 287 2570 81 12020339 10.1001/jama.287.19.2570 1:CAS:528:DC%2BD38Xjs1GltLc%3D (Pubitemid 34517204)
18. K Pyörälä M Laakso M Uusitupa 1987 Diabetes and atherosclerosis: an epidemiologic view Diabetes Metab Rev. 3 463 524 3552530 10.1002/dmr.5610030206 (Pubitemid 17050766)
19. SM Haffner S Lehto T Rönnemaa K Pyörälä M Laakso 1998 Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229 34 9673301 10.1056/NEJM199807233390404 1:STN:280:DyaK1czivVKgsg%3D%3D (Pubitemid 28350165)
20. A Rudijanto 2007 The expression and down stream effect of lectin like-oxidized low Density lipoprotein 1 (LOX-1) in hyperglycemic state Acta Med Indones. 39 36 43 17939209
21. JM Hayden PD Reaven 2000 Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors Curr Opin Lipidol 11 519 28 11048895 10.1097/00041433-200010000-00010 1:CAS:528:DC%2BD3cXnt12js7g%3D
22. PT McSorley IS Young J McEneny H Fee DR McCance 2004 Susceptibility of low-density lipoprotein to oxidation and circulating cell adhesion molecules in young healthy adult offspring of parents with type 2 diabetes Metabolism 53 755 9 15164324 10.1016/j.metabol.2003.11.026 1:CAS:528:DC%2BD2cXkt1CmsrY%3D (Pubitemid 38880907)
23. OA Hussein Y Gefen JM Zidan EY Karochero AS Luder NN Assy, et al. 2007 LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients Clinica Chimica Acta. 377 114 8 10.1016/j.cca.2006.09.002 1:CAS:528:DC%2BD28XhtleisLvM (Pubitemid 44908238)
24. S Pennathur JW Heinecke 2007 Mechanisms for oxidative stress in diabetic cardiovascular disease Antiox Redox Sig. 9 955 69 10.1089/ars.2007.1595 1:CAS:528:DC%2BD2sXltlOiurY%3D (Pubitemid 46919596)
25. M Kawamura JW Heinecke A Chait 1994 Pathophysiological concentrations of glucose promote oxidative modification of low-density-lipoprotein by a superoxide-dependent pathway J Clin Invest 94 771 8 8040332 10.1172/JCI117396 1:CAS:528:DyaK2cXltlWnt70%3D (Pubitemid 24251010)
26. R Piga Y Naito S Kokura O Handa T Yoshikawa 2007 Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells Atherosclerosis 193 328 34 17097661 10.1016/j.atherosclerosis.2006.09.016 1:CAS:528:DC%2BD2sXotVClsro%3D (Pubitemid 47058120)
27. MR Dasu S Devaraj I Jialal 2007 High glucose induces IL-1 beta expression in human monocytes: mechanistic insights Am J Physiol Endocrinol Metab 293 E337 E46 17426109 10.1152/ajpendo.00718.2006 1:CAS:528:DC%2BD2sXosV2mt7w%3D (Pubitemid 47105949)
28. C Cipolletta KE Ryan EV Hanna ER Trimble 2005 Activation of peripheral blood CD14(+) monocytes occurs in diabetes Diabetes 54 2779 86 16123369 10.2337/diabetes.54.9.2779 1:CAS:528:DC%2BD2MXhtVSjs7jJ (Pubitemid 41233602)
29. JL Mehta J Chen PL Hermonat F Romeo G Novelli 2006 Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders Cardiovasc Res 69 36 45 16324688 10.1016/j.cardiores.2005.09.006 1:CAS:528:DC%2BD2MXhtlGisb3O (Pubitemid 41814809)
30. M Rodriguez-Moran F Guerrero-Romero 1999 Increased levels of C-reactive protein in noncontrolled type II diabetic subjects J Diabet Complicat 13 211 5 10.1016/S1056-8727(99)00047-1 1:STN:280:DC%2BD3c%2FotlWmsw%3D%3D
31. FP Schena L Gesualdo 2005 Pathogenetic Mechanisms of Diabetic Nephropathy J Am Soc Nephrol 16 S30 3 15938030 10.1681/ASN.2004110970 1:CAS:528: DC%2BD2MXivVOmt70%3D (Pubitemid 41725079)
32. T Deckert B Feldt-Rasmussen K Borch-Johnsen T Jensen A Kofoed-Enevoldsen 1989 Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32 219 26 2668076 10.1007/BF00285287 1:STN:280:DyaL1MzjvFSjtA%3D%3D (Pubitemid 19136363)
33. DA Long KL Price J Herrera-Acosta RJ Johnson 2004 How does angiotensin II cause renal injury? Hypertension 43 722 3 14967828 10.1161/01.HYP.0000120964. 22281.3e 1:CAS:528:DC%2BD2cXjtVelu7k%3D (Pubitemid 38405576)
34. JM Forbes ME Cooper 2007 Diabetic nephropathy: where hemodynamics meets metabolism Exp Clin Endocrinol Diabetes. 115 69 84 17318765 10.1055/s-2007- 949721 1:CAS:528:DC%2BD2sXjvVynur4%3D (Pubitemid 46408113)
35. KJ Kelly P Wu CE Patterson C Temm JH Dominguez 2008 LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes Am J Physiol Renal Physiol. 294 F1136 45 18322020 10.1152/ajprenal.00396.2007 1:CAS:528:DC%2BD1cXmtVWnur4%3D
36. T Aoyama H Fujiwara T Masaki T Sawamura 1999 Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultred endothelial cell J Mol Cell Cardiol 31 2101 14 10640439 10.1006/jmcc.1999.1041 1:CAS:528:DC%2BD3cXkvVSjsA%3D%3D (Pubitemid 30029022)
37. D Li JL Mehta 2000 Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors Arterioscler Thromb Vasc Biol 20 1116 22 10764682 10.1161/01.ATV.20.4.1116 1:CAS:528:DC%2BD3cXjtV2hsLc%3D (Pubitemid 30207591)
38. G Marsche S Levak-Frank O Quehenberger R Heller W Sattler E Malle 2001 Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells FASEB J 15 1095 7 11292679 1:CAS:528:DC%2BD3MXivFOruro%3D
39. K Oka T Sawamura K-i Kikuta S Itokawa N Kume T Kita, et al. 1998 Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells Proc Natl Acad Sci USA 95 9535 40 9689115 10.1073/pnas.95.16.9535 1:CAS:528:DyaK1cXltlClsLs%3D (Pubitemid 28506266)
40. M Honjo K Nakamura K Yamashiro J Kiryu H Tanihara LM McEvoy, et al. 2003 Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation Proc Natl Acad Sci USA 100 1274 9 12538855 10.1073/pnas.0337528100 1:CAS:528:DC%2BD3sXhtF2gur4%3D (Pubitemid 36183992)
41. M Kakutani T Masaki T Sawamura 2000 A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 Proc Natl Acad Sci USA 97 360 4 10618423 10.1073/pnas.97.1.360 1:CAS:528: DC%2BD3cXjvVGhsA%3D%3D (Pubitemid 30055836)
42. T Shimaoka N Kume M Minami K Hayashida T Sawamura T Kita, et al. 2001 LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria J Immunol 166 1508 14
43. JE Murphy D Tacon PR Tedbury JM Hadden S Knowling T Sawamura, et al. 2006 LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells Biochem J 393 107 15 16146427 10.1042/BJ20051166 1:CAS:528:DC%2BD28XivVKnuw%3D%3D (Pubitemid 43049307)
44. T Jonoab A Miyazakia R Nagaia T Sawamurac T Kitamurab S Horiuchia 2002 Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE) FEBS Lett 511 170 4 10.1016/S0014-5793(01)03325-7 (Pubitemid 34127844)
45. T Murase N Kume R Korenaga J Ando T Sawamura T Masaki, et al. 1998 Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells Circ Res 83 328 33 9710126 1:CAS:528: DyaK1cXltlegtbo%3D (Pubitemid 28371323)
46. DY Li YC Zhang MI Philips T Sawamura JL Mehta 1999 Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation Circ Res 84 1043 9 10325241 1:CAS:528:DyaK1MXjtFCjtrY%3D (Pubitemid 29227683)
47. O Hofnagel B Luechtenborg K Stolle S Lorkowski H Eschert G Plenz, et al. 2004 Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 24 1789 95 15271788 10.1161/01.ATV.0000140061.89096.2b 1:CAS:528:DC%2BD2cXotVOns7Y%3D (Pubitemid 39350293)
48. M Nagase K Ando T Nagase S Kaname T Sawamura T Fujita 2001 Redox-sensitive regulation of LOX-1 gene expression in vascular endothelium Biochem Biophys Res Commun 281 720 5 11237717 10.1006/bbrc.2001.4374 1:CAS:528:DC%2BD3MXhsFOgtrY%3D (Pubitemid 32917860)
49. L Li N Roumeliotis T Sawamura G Renier 2004 C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction Circ Res 95 877 83 15472120 10.1161/01.RES.0000147309.54227.42 1:CAS:528:DC%2BD2cXoslSksr0%3D (Pubitemid 39435002)
50. M Minami N Kume H Kataoka M Morimoto K Hayashida T Sawamura, et al. 2000 Transforming growth factor-beta (1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 Biochem Biophys Res Commun 272 357 61 10833418 10.1006/bbrc.2000.2778 1:CAS:528:DC%2BD3cXjs12gur4%3D (Pubitemid 30444622)
51. KCB Tan SWM Shiu Y Wong L Leng R Bucala 2008 Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus J Lipid Res. 49 1438 44 18408244 10.1194/jlr.M700551-JLR200 1:CAS:528:DC%2BD1cXotVOqurg%3D
52. L Li T Sawamura G Renier 2004 Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation Circ Res 94 892 901 15001526 10.1161/01.RES.0000124920.09738.26 1:CAS:528:DC%2BD2cXivVKqsbs%3D (Pubitemid 38490066)
53. T Navarra SD Turco S Berti G Basta 2010 The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: catdiovascular inplications J Atheroscler Thromb 17 317 31 20009416 10.5551/jat.3228 1:CAS:528:DC%2BC3MXhvVersbk%3D
54. F Kamezaki K Yamashita H Tasaki N Kume H Mitsuoka T Kita, et al. 2009 Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease Int J Cardiol 134 285 7 18367271 10.1016/j.ijcard.2007.12.069
55. K Hayashida N Kume T Murase M Minami D Nakagawa T Inada, et al. 2005 Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis Circulation 112 812 8 16061745 10.1161/CIRCULATIONAHA.104.468397 1:CAS:528:DC%2BD2MXmvVKrtLg%3D (Pubitemid 41170066)
56. G Renier F Maingrette L Li 2007 Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) Curr Diabetes Rev. 3 103 10 10.2174/157339907780598225 1:CAS:528:DC%2BD2sXms1yhurY%3D (Pubitemid 46773850)
57. TE Brinkley N Kume H Mitsuoka DA Phares JM Hagberg 2008 Elevated soluble lectin-like oxidized LDL receptor 1 (LOX-1) levels in obese postmenopausal women Obesity (Silver Spring). 16 1454 6 10.1038/oby.2008.213 1:CAS:528: DC%2BD1cXmsFCgu7g%3D (Pubitemid 351770510)
58. H Kosaka H Yoneyama L Zhang S Fujii A Yamamoto J Igarashi 2003 Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine FASEB J 17 636 43 12665476 10.1096/fj.02-0585com 1:CAS:528:DC%2BD3sXislGku70%3D (Pubitemid 37221148)
59. JH Bräsen M Nieminen-Kelhä D Markmann E Malle W Schneider HH Neumayer, et al. 2005 Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1)-mediated pathway and vascular oxidative injury in older-age rat renal transplants Kidney Int 67 1583 94 15780115 10.1111/j.1523-1755.2005. 00240.x (Pubitemid 40463139)
60. Y Hyodo H Miyake Y Kondo M Fujisawa 2009 Downregulation of lectin-like oxidized low-density lipoprotein receptor-1 after ischemic preconditioning in ischemia-reperfused rat kidneys Urology 73 906 10 19167041 10.1016/j.urology. 2008.11.033
61. C Hu BY Kang J Megyesi GP Kaushal RL Safirstein JL Mehta 2009 Deletion of LOX-1 attenuates renal injury following angiotensin II infusion Kidney Int 76 521 7 19553911 10.1038/ki.2009.234 1:CAS:528:DC%2BD1MXhtVWiurjL
62. X Chen T Zhang G Du 2008 Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay Cell Biochem Funct. 26 760 70 18636435 10.1002/cbf.1502 1:CAS:528:DC%2BD1cXhsVKgurjM
63. T Jono A Miyazaki R Nagai T Sawamura T Kitamura S Horiuchi 2002 Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE) FEBS Lett 511 170 4 11821070 10.1016/S0014-5793(01)03325-7 1:CAS:528:DC%2BD38XovFekug%3D%3D (Pubitemid 34127844)
64. Y Iwashima M Eto A Hata K Kaku S Horiuchi F Ushikubi, et al. 2000 Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages Biochem Biophys Res Commun 277 368 80 11032732 10.1006/bbrc.2000.3685 1:CAS:528:DC%2BD3cXntlGitrw%3D
65. SWM Shiu KCB Tan Y Wang L Leng R Bucala 2009 Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus Atherosclerosis 203 522 7 18755461 10.1016/j.atherosclerosis.2008.07.012 1:CAS:528:DC%2BD1MXjslyitbs%3D
66. A Taye AH Saad AH Kumar H Morawietz 2010 Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose Eur J Pharmacol 627 42 8 19878672 10.1016/j.ejphar.2009. 10.045 1:CAS:528:DC%2BC3cXksVegsw%3D%3D
67. F Maingrette G Renier 2005 Linoleic acid increases lectin-like oxidized LDL receptor-1 (LOX-1) expression in human aortic endothelial cells Diabetes 54 1506 13 15855339 10.2337/diabetes.54.5.1506 1:CAS:528:DC%2BD2MXktVCksbs%3D (Pubitemid 40586683)
68. D Li V Williams L Liu H Chen T Sawamura F Romeo, et al. 2003 Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction J Am Coll Cardiol 41 1048 55 12651056 10.1016/S0735-1097(02)02966-2 1:CAS:528:DC%2BD3sXislejsb8%3D (Pubitemid 36315552)
69. C Hu J Chen A Dandapat Y Fujita N Inoue Y Kawase, et al. 2008 LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice J Mol Cell Cardiol 44 76 83 18022184 10.1016/j.yjmcc.2007.10.009
70. C Hu A Dandapat J Chen Y Fujita N Inoue Y Kawase K Jishage H Suzuki T Sawamura JL Mehta 2007 LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion Cardiovasc Res 76 292 302 17707356 10.1016/j.cardiores.2007.07.003 1:CAS:528:DC%2BD2sXhtFGrtLfJ (Pubitemid 350198599)
71. Andersson C, Gislason GH, Jørgensen CH, Hansen PR, Vaag A, Sørensen R. et al. Diabetes Res Clin Pract: Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure; 2011 Aug 8 [Epub ahead of print].
72. IV Smirnova T Sawamura MS Goligorsky 2004 Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency Am J Physiol Renal Physiol. 287 F25 32 15010359 10.1152/ajprenal.00449.2003 1:CAS:528:DC%2BD2cXmtVektr8%3D (Pubitemid 38780579)
73. KJ Kelly JH Dominguez 2010 Treatment of the post-ischaemic inflammatory syndrome of diabetic nephropathy Nephrol Dial Transplant 25 3204 12 20466672 10.1093/ndt/gfq217 1:CAS:528:DC%2BC3cXht1Wgs7%2FO
74. N Yamamoto M Toyoda M Abe T Kobayashi K Kobayashi M Kato, et al. 2009 Lectin-like oxidized LDL receptor-1 (LOX-1) expression in the tubulointerstitial area likely plays an important role in human diabetic nephropathy Intern Med. 48 189 94 19218767 10.2169/internalmedicine.48.1251
75. M Zhang X Gao J Wu D Liu H Cai L Fu, et al. 2010 Oxidized high-density lipoprotein enhances inflammatory activity in rat mesangial cells Diabetes Metab Res Rev. 26 455 63 20623482 10.1002/dmrr.1102 1:CAS:528:DC%2BC3cXht1aqsbfJ
76. Futrakul N, Futrakul P. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes. Int J Vasc Med. Epub 2011 May 24.
77. JH Dominguez JL Mehta D Li P Wu KJ Kelly CS Packer, et al. 2008 Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations Am J Physiol Renal Physiol. 294 F110 9 17989113 10.1152/ajprenal.00013.2007 1:CAS:528:DC%2BD1cXhtVKnsbg%3D
78. R Collins J Armitage S Parish P Sleigh R Peto 2003 MRC/BHF heart protection study of cholesterol lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2005 16 12814710 10.1016/S0140-6736(03)12475-0
79. HM Colhoun DJ Betteridge PN Durrington GA Hitman HA Neil SJ Livingstone, et al. 2004 Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 364 685 96 15325833 10.1016/S0140-6736(04)16895-5 1:CAS:528:DC%2BD2cXmvFWltrY%3D (Pubitemid 39140624)
80. DY Li HJ Chen JL Mehta 2001 Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation Cardiovasc Res 52 130 5 11557241 10.1016/S0008-6363(01)00371-6 1:CAS:528:DC%2BD3MXms1OltLo%3D (Pubitemid 32835246)
81. YH Yu Y Wang B Dong SZ Sun Y Chen XH Meng, et al. 2005 Fluvastatin prevents renal injury and expression of lectin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia Chin Med J (Engl). 118 621 6 1:CAS:528:DC%2BD2MXks1Wlsb4%3D (Pubitemid 40585022)
82. M Khaidakov W Wang JA Khan BY Kang PL Hermonat JL Mehta 2009 Statins and angiogenesis: is it about connections? Biochem Biophys Res Commun 387 543 7 19615978 10.1016/j.bbrc.2009.07.057 1:CAS:528:DC%2BD1MXps1Clsb0%3D
83. J Costa M Borges C David CA Vaz 2006 Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials BMJ 332 1115 24 16585050 10.1136/bmj.38793.468449.AE 1:CAS:528:DC%2BD28XlvVOqsLk%3D (Pubitemid 44480873)
84. J Mehta B Hu J Chen D Li 2003 Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation Arterioscler Thromb Vasc Biol 23 2203 8 12958047 10.1161/01.ATV.0000094411.98127.5F 1:CAS:528:DC%2BD3sXpsVGht70%3D (Pubitemid 37532321)
85. Y Chiba T Ogita K Ando T Fujita 2001 PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells Biochem Biophys Res Commun 286 541 6 11511093 10.1006/bbrc.2001.5361 1:CAS:528: DC%2BD3MXmtVWgsr0%3D (Pubitemid 32912980)
86. L Li T Sawamura G Renier 2003 Glucose enhances endothelial LOX-1 expression role for LOX-1 in glucose-induced human monocyte adhesion to endothelium Diabetes 52 1843 50 12829655 10.2337/diabetes.52.7.1843 1:CAS:528:DC%2BD3sXltlWhurg%3D (Pubitemid 36792477)
87. L Wang L Zhang Y Yu Y Wang N Niu 2008 The protective effects of taurine against early renal injury in STZ-induced diabetic rats, correlated with inhibition of renal LOX-1-mediated ICAM-1 expression Ren Fail 30 763 71 18791949 10.1080/08860220802272563 1:CAS:528:DC%2BD1cXhtFeitbzF
88. N Ouslimani M Mahrouf J Peynet D Bonnefont-Rousselot C Cosson A Legrand, et al. 2007 Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1 Metabolism 56 308 13 17292717 10.1016/j.metabol.2006.10.010 1:CAS:528: DC%2BD2sXhs1Cltrs%3D (Pubitemid 46209221)
89. L Li G Renier 2009 The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells Atherosclerosis 204 40 6 18801483 10.1016/j.atherosclerosis.2008.08.008 1:CAS:528:DC%2BD1MXlsVKgu7k%3D
90. A Rudijanto 2010 Calcium channel blocker (diltiazem) inhibits apoptosis of vascular smooth muscle cell exposed to high glucose concentration through lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) pathway Acta Med Indones. 42 59 65 20973294
91. K Yamagata A Miyashita M Chino H Matsufuji 2011 Apigenin inhibits tumor necrosis factor alpha plus high glucose-induced LOX-1 expression in human endothelial cells Microvasc Res 81 60 7 21040737 10.1016/j.mvr.2010.10.005 1:CAS:528:DC%2BC3MXjsVOktA%3D%3D
92. JL Mehta J Chen F Yu DY Li 2004 Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells Cardiovasc Res 64 243 9 15485683 10.1016/j.cardiores.2004.07.002 1:CAS:528:DC%2BD2cXos1ertb8%3D (Pubitemid 39361685)
93. M Yuan N Konstantopoulos J Lee L Hansen ZW Li M Karin SE Shoelson 2001 Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 293 1673 7 11533494 10.1126/science. 1061620 1:CAS:528:DC%2BD3MXms1Chtrw%3D (Pubitemid 32807849)
94. M Khaidakov J Szwedo S Mitra S Ayyadevara M Dobretsov J Lu, et al. 2010 Antiangiogenic and antimitotic effects of aspirin in hypoxia-reoxygenation modulation of the LOX-1-NADPH oxidase axis as a potential mechanism J Cardiovasc Pharmacol 56 635 41 20881612 10.1097/FJC.0b013e3181f801e4 1:CAS:528: DC%2BC3MXjs1WmsQ%3D%3D